Insulet PODD Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Insulet in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Insulet's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Insulet's accounts payable?
- Insulet (PODD) reported accounts payable of $149.8M in Q1 2026.
- How has Insulet's accounts payable changed year-over-year?
- Insulet's accounts payable increased by 160.1% year-over-year, from $57.6M to $149.8M.
- What is the long-term trend for Insulet's accounts payable?
- Over 5 years (2020 to 2025), Insulet's accounts payable has grown at a 6.8% compound annual growth rate (CAGR), from $54.1M to $75M.
- What does accounts payable mean?
- Money the company owes to its suppliers for goods and services.
- How do you interpret accounts payable?
- An increase may suggest improved cash management or delayed payments, while a decrease may indicate faster settlement of obligations.
- How does accounts payable compare across companies?
- Typically benchmarked against days payable outstanding (DPO) relative to industry peers in the medical device sector.